CRIS Current Research Information System

MURATORI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.507
EU - Europa 4.372
AS - Asia 2.554
AF - Africa 258
SA - Sud America 20
OC - Oceania 16
Totale 13.727
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.481
GB - Regno Unito 1.268
CN - Cina 894
VN - Vietnam 751
IT - Italia 643
SE - Svezia 625
DE - Germania 594
SG - Singapore 570
UA - Ucraina 298
IN - India 249
RU - Federazione Russa 247
IE - Irlanda 165
FR - Francia 154
EE - Estonia 86
ZA - Sudafrica 82
TG - Togo 70
CH - Svizzera 64
CI - Costa d'Avorio 60
FI - Finlandia 57
BG - Bulgaria 34
NL - Olanda 31
JO - Giordania 28
BE - Belgio 27
CA - Canada 22
NG - Nigeria 20
SC - Seychelles 20
AT - Austria 19
GR - Grecia 16
HR - Croazia 13
ID - Indonesia 12
BR - Brasile 11
AU - Australia 10
IR - Iran 10
RO - Romania 8
JP - Giappone 7
TR - Turchia 7
NZ - Nuova Zelanda 6
PL - Polonia 6
CZ - Repubblica Ceca 5
HK - Hong Kong 5
PT - Portogallo 5
EG - Egitto 4
IQ - Iraq 4
MX - Messico 4
AR - Argentina 3
BD - Bangladesh 3
ES - Italia 3
MY - Malesia 3
CL - Cile 2
EC - Ecuador 2
KR - Corea 2
LB - Libano 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
BO - Bolivia 1
CY - Cipro 1
DK - Danimarca 1
FK - Isole Falkland (Malvinas) 1
MA - Marocco 1
NO - Norvegia 1
PH - Filippine 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TW - Taiwan 1
Totale 13.727
Salva come PNG Salva come JPEG
Città #
Southend 1.129
Fairfield 828
Chandler 595
Dong Ket 585
Ashburn 517
Singapore 476
Woodbridge 402
Houston 390
Seattle 384
Santa Clara 361
Wilmington 352
Cambridge 294
Princeton 253
Ann Arbor 247
Jacksonville 193
Dublin 164
Boardman 153
Bologna 123
Nanjing 115
Padova 103
Westminster 101
Berlin 90
Jinan 83
Lomé 70
Abidjan 60
Shenyang 55
Saint Petersburg 53
Bern 52
Helsinki 52
San Diego 51
Beijing 46
Milan 41
Hebei 40
Bremen 39
Mülheim 39
Des Moines 38
Changsha 37
Nanchang 35
Sofia 32
Guangzhou 31
Turin 29
Amman 28
Brussels 27
Tianjin 26
New York 25
Medford 24
Haikou 21
Abeokuta 20
Hangzhou 20
Mahé 20
Rome 20
Falls Church 19
Frankfurt am Main 19
Jiaxing 19
Dearborn 18
Los Angeles 18
Phoenix 18
Taiyuan 18
Zhengzhou 18
Bühl 17
Chengdu 15
Fremont 15
London 15
Taizhou 15
Verona 15
Fuzhou 14
Ningbo 14
Shanghai 14
Falkenstein 13
Olalla 13
Redwood City 13
Vienna 13
Yubileyny 13
Norwalk 12
Toronto 12
Washington 12
Jakarta 10
Moscow 10
Nuremberg 10
San Francisco 10
Amsterdam 9
Leawood 9
Lanzhou 8
Wuhan 8
Modena 7
Mumbai 7
Paris 7
Parma 7
Tokyo 7
Andover 6
Buffalo 6
Chongqing 6
Florence 6
Fort Worth 6
Pontassieve 6
Qingdao 6
Xi'an 6
Botosani 5
Kunming 5
Mountain View 5
Totale 9.523
Salva come PNG Salva come JPEG
Nome #
A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis 223
Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil antibodies in coeliac disease before and after gluten free diet. 214
Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. 193
Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type. 181
Clinical and serological profile of primary biliary cirrhosis in men. 180
Clinical features of type 1 autoimmune hepatitis in elderly Italian patients 178
Acute icteric hepatitis induced by a short course of low-dose cyclophosphamide in a patient with lupus nephritis 173
Antinuclear antibodies as ancillary markers in primary biliary cirrhosis. 173
A COMPLEX IMMUNOREGULATORY DEFICIENCY CHARACTERISES TYPE 1 AUTOIMMUNE HEPATITIS. 172
Application of the 2010 American Association for the study of liver diseases criteria of remission to a cohort of Italian patients with autoimmune hepatitis. 171
Anti-actin IgA antibodies in severe coeliac disease 167
Autoimmune enteropathy and rheumatoid arthritis: A new association in the field of autoimmunity. 166
Anti-nuclear antibodies giving the “multiple nuclear dots” (MND) or the “rim-like/membranous” (RL/M) patterns: diagnostic accuracy for primary biliary cirrhosis. 165
Imaging-based diagnosis of benign lesions and pseudolesions in the cirrhotic liver 164
Multiple nuclear dots and rim-like/membranous IgG isotypes in primary biliary cirrhosis. 163
A case of leptospirosis simulating colon cancer with liver metastases 160
Antimitochondrial antibodies positive autoimmune hepatitis with acute onset 159
Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C 156
Antinuclear antibodies in COVID 19 153
Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis. 151
'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? 150
Autoimmune liver disease in patients with systemic lupus erythematosus: a retrospective analysis of 147 cases. 150
SPECIFICITY OF ANTI-SP100 ANTIBODY FOR PRIMARY BILIARY CIRRHOSIS. 148
Autoantibodies in Autoimmune Hepatitis 145
Autoimmune liver disease and concomitant extrahepatic autoimmune disease 144
Diagnosis and therapy of autoimmune hepatitis. 141
Autoimmune liver disease 2007. 140
Antifilamentous Actin Antibodies by ELISA for the Diagnosis of Type 1 Autoimmune Hepatitis. 139
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 138
Virological analysis, genotypes and mutational patterns of the HBV pre-core/core gene in HBV/HCV-related hepatocellular carcinoma. 138
CLINICAL FEATURES OF PRIMARY BILIARY CIRRHOSIS IN YOUNG AND ELDERLY PATIENTS. 137
PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis. 136
Clinical and serological profile of primary biliary cirrhosis in young and elderly patients. 134
Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study 134
Autoimmune hepatitis in Italy: the Bologna experience. 133
Clinical Impact and behaviour of serum autoantibodies in adult liver transplantation 133
Antitransglutaminase antibodies and giardiasis 132
Deamidated gliadin Peptide antibodies as a routine test for celiac disease: a prospective analysis. 131
Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype 131
The western immunoblotting pattern of anti-mitochondrial antibodies is independent of the clinical expression of primary biliary cirrhosis 131
Anti-ribosomal P protein antibody: an autoreactivity devoid of prognostic value in patients with autoimmune hepatitis. 130
Features and Progression of Asymptomatic Autoimmune Hepatitis in Italy 130
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice 130
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 130
Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C. 130
Anti-saccharomyces cerevisiae antibodies (ASCA) in coeliac disease. 129
Antibodies to soluble liver antigen in patients with various liver diseases: A multicentre study 129
Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value 128
Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: An Italian multicentre study 125
Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study 125
COVID-19 and Immunological Dysregulation: Can Autoantibodies be Useful? 124
Evidence of a genetic basis for the different geographic occurrences of liver/kidney microsomal antibody type 1 in hepatitis C. 123
Immunoglobulin GM and KM allotypes and prevalence of anti-LKM1 autoantibodies in patients with hepatitis C virus infection. 120
The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. 118
Redistribution of regulatory T-cells across the evolving stages of chronic hepatitis C. 117
PML NUCLEAR BODY COMPONENT SP140 IS A NOVEL AUTOANTIGEN IN PRIMARY BILIARY CIRRHOSIS. 114
Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature. 113
Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis. 113
Diagnostic approach to autoimmune hepatitis 112
Primary biliary cirrhosis specific anti-nuclear antibodies in patients from Spain. 111
Celiac disease in autoimmune cholestatic liver disorders 110
Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51 108
Standardization of Autoantibody Testing in Autoimmune Hepatitis 107
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis. 105
Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis. 105
Specific antinuclear reactivities in primary biliary cirrhosis 104
Hepatic steatosis in chronic hepatitis C: impact on response to anti-viral treatment with peg-interferon and ribavirin 103
Autoantibodies in antimithocondrial antibodies negative primary biliary cholangitis. 103
INCREASED REGULATORY POTENTIAL AND IMBALANCE OF THE VDELTA1/VDELTA2 RATIO IN PATIENTS WITH DIFFERENT MANIFESTATIONS OF HEPATITIS C. 103
Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis. 102
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 101
Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases. 100
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies 100
Serum Smooth Muscle Antibodies (SMA). 98
Usefulness of Antibodies to Deamidated Gliadin Peptides in Celiac Disease Diagnosis and Follow-up. 98
DETECTION OF MND AND RL/M ANTI-NUCLEAR ANTIBODIES PATTERNS: A RELIABLE DIAGNOSTIC TOOL IN ANTI-MITOCHONDRIAL ANTIBODIES NEGATIVE PRIMARY BILIARY CIRRHOSIS. 98
Diagnosis of primary biliary cholangitis in a "teen" male patient 98
null 96
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 96
Response to Efe et al. 95
null 92
Hepatitis C and autoreactivity. 91
Identification of new autoantigens by protein array indicates a role for IL4 neutralization in Autoimmune Hepatitis. 90
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 90
Le fonti energetiche rinnovabili nel contesto internazionale: il solare fotovoltaico ed i suoi sviluppi tecnologici 89
Review article: autoimmune hepatitis - current management and challenges 89
Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis 88
Non organ specific autoantibodies in children with chronic hepatitis C virus infection 87
Current topics in autoimmune hepatitis. 87
Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment 85
Genetic distinction between autoimmune hepatitis in Italy and North America 84
Numerical investigation of blood flow in a stenotic artery. Target 1: geometry and rheology 83
Susceptibility to thyroid disorders in hepatitis C 82
Smooth Muscle Antibodies 81
Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis. 79
Validation of simplified diagnostic criteria for autoimmune hepatitis in Italian patients. 77
Diagnostic difficulties, therapeutic strategies, and performance of scoring systems in patients with autoimmune hepatitis and concurrent hepatitis B/C 76
Autoantibodies to enterocytes in patients with villous atrophy unresponsive to gluten free diet. 76
LKM1-positive type 2 autoimmune hepatitis following allogenic haematopoietic stem-cell transplantation. 75
Liver fibrosis may reduce the efficacy of budesonide in the treatment of autoimmune hepatitis and overlap syndrome. 74
Totale 12.383
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.795
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.795
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.073 0 0 0 0 0 0 0 0 430 273 166 204
2020/20212.187 327 125 61 79 70 103 56 186 132 129 92 827
2021/20222.455 211 49 169 220 201 124 50 168 100 177 567 419
2022/20232.442 326 342 128 314 139 186 87 135 388 95 189 113
2023/2024667 48 112 44 67 61 98 32 55 22 33 49 46
2024/20251.925 156 422 292 211 485 130 135 57 37 0 0 0
Totale 13.997